Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate and Propranolol in Burn Patients
NCT02452255Phase 3Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Nov 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fenofibrate, propranolol in burn injury, sponsored by The University of Texas Medical Branch at Galveston. Started Nov 2015; status: terminated.
02
Drugs
fenofibratepropranolol
03
Conditions
burn injury
Beyond the preview
Go deeper on NCT02452255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02452255.